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Abstract: One of the current challenges in medicine is monitoring the patients’ depth of 
general anaesthesia (DGA). Accurate assessment of the depth of anaesthesia contributes to 
tailoring  drug  administration  to  the  individual  patient,  thus  preventing  awareness  or 
excessive anaesthetic depth and improving patients’ outcomes. In the past decade, there 
has been a significant increase in the number of studies on the development, comparison 
and  validation  of  commercial  devices  that  estimate  the  DGA  by  analyzing  electrical 
activity of the brain (i.e., evoked potentials or brain waves). In this paper we review the 
most frequently used sensors and mathematical methods for monitoring the DGA, their 
validation in clinical practice and discuss the central question of whether these approaches 
can, compared to other conventional methods, reduce the risk of patient awareness during 
surgical procedures. 
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1. Introduction 
1.1. Why is it necessary to monitor the depth of general anaesthesia? 
Many surgical procedures would not be possible without the patient entering a state of general 
anaesthesia (GA). The essential features of a successful GA, displayed by the patient, are a reversible 
loss of consciousness with a lack of movement, a lack of awareness,  unresponsiveness to painful 
stimuli and a lack of recall of the surgical intervention. Inadequate GA may lead to intraoperative 
awareness with recall (due to patient underdosage) or to prolonged recovery and an increased risk of 
postoperative complications for the patient (due to overdosage). An important contributing factor to 
inadequate GA is our current limited ability to evaluate the levels of consciousness 1. 
The  incidence  of  awareness  has  been  reduced  from  about  1–2%  in  unselected  patients  in  the  
1980s 2 to about 0.1% at present 3-6. However, certain surgical procedures (for example caesarean 
section or cardiac surgery) or high risk patients have a substantially increased risk of awareness 7. 
The consequences of intraoperative awareness range from an absence of prolonged after-effects to a 
post-traumatic stress disorder 7. In comparison, worldwide anaesthesia-related mortality rates during 
the 1990 to 2006 period ranged between 75 (in Thailand) and 1 (in the USA or Japan) per 100,000 
anaesthetic procedures. The main causes of anaesthesia-related mortality were problems with airway 
management and cardiovascular events related to anaesthesia and drug administration 8. 
Important signs of inadequate patient GA (Figure 1), signs which develop in response to stress or 
painful stimuli, are movement, increased breathing or heart rate and increased blood pressure  9. 
These warning signs are often attenuated since many surgical procedures require administration of a 
muscle relaxant or the patient receives medication that affects the heart rate and blood pressure 9. 
Avoidance of muscle relaxants is no guarantee of avoiding awareness. Studies have reported patients 
with awareness under non-relaxant anaesthesia 3-5. Fortunately, such awareness is very rare and very 
rarely reported as unpleasant 3. 
Figure 1. The relationship between surgical stimuli, general anaesthetics and awareness. 
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It is generally believed that awareness will not occur if GA is maintained with a volatile agent 
delivered to the patient’s blood at a concentration of at least 0.5 minimum alveolar concentration 
(MAC) 9. However, for some patients, the use of total intravenous anaesthesia techniques is more 
appropriate 3,10-13. Individual variations in patient drug requirements will also lead to occasional 
over dosage or under dosage with both volatile-based and intravenous-based techniques 9,11. Failure 
to adjust the anaesthetic requirements to individual variations in patient drug requirements and to the 
intensity of pain stimulation during a specific surgery procedure will also lead to over dosage or under 
dosage with both volatile-based and intravenous-based techniques 9,11. 
1.2. Monitoring anaesthetic delivery is not the same as monitoring anaesthetic effect 
The potencies of general anaesthetics range over at least five orders of magnitude 14. However, 
for  any  given  anaesthetic,  the  concentration  at  which  consciousness  is  lost  is  well  defined.  For 
intravenous or volatile anaesthetics, the transition from the conscious to the unconscious state occurs 
abruptly over  a change  in  concentration of only a factor of less than 1.6  14. The physiological 
mechanism for this abrupt switch between consciousness and unconsciousness was explained by the 
intrinsic  bi-stability  of  thalamocortical  neurons  coupled  with  the  reciprocal  inhibitory  connections 
between  hypothalamic  sleep-promoting  centres  and  the  arousal  nuclei  in  the  midbrain  and  the 
brainstem, which would tend to favour rapid transitions between high and low states of ascending 
arousal 14. 
Administration of at least 0.5 MAC of a volatile anaesthetic agent should prevent awareness 15 
and most anaesthetists employ this approach to prevent awareness in their daily practice 9. Similar 
results can be obtained with total intravenous infusion devices that incorporate predicted plasma and 
effect site concentrations 16. However, since we measure the volatile anaesthetic's concentration in 
the  lungs  and  only  simulate  the  concentration  of  intravenous  anaesthetic  drugs,  we  do  not  know 
exactly and accurately what anaesthetic concentration is reaching the brain at all times throughout the 
surgical procedure. In other words, volatile-based and intravenous-based anaesthetic devices measure 
or predict drug concentration not drug effect 9. 
Table 1. Basic characteristics of EEG wave bands. 
1.3. Monitoring anaesthetic depth 
The transition from a state of wakefulness to a state of GA is accompanied by profound changes in 
the  brain’s  spontaneous  electrical  activity  recorded  from  electrodes  placed  on  the  scalp  (an 
electroencephalograph or EEG). The EEG reflects the compound synaptic activity of excitatory and 
inhibitory post-synaptic potentials generated by cortical neurons 17. However, to achieve an optimal 
EEG bands  Frequency (Hz)  Amplitude (mV)  Generator of brain waves 
ʱ (alfa)  8–13  20–60  thalamus 
β (beta)  13–30  2–20  cortex 
γ (gama)  30–70  3–5  thalamus 
ʴ (delta)  0,5–4  20–200  talamus 
θ (theta)  4–7  20–100  hippocampus and neocortex Sensors 2010, 10                                       
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level  of  GA,  it  is  not  possible,  nor  practical,  to  adjust  the  delivery  of  volatile  or  intravenous 
anaesthetics on the basis of an on-line EEG 17. Only the advances in computer hardware and signal 
processing algorithms have enabled the processing of EEG signals (Table 1) and the development of 
monitors that estimate the depth of general anaesthesia (DGA) on a near to on-line basis 9,17-20. To 
understand how DGA monitors work, their respective advantages and disadvantages, it is necessary to 
understand the theoretical foundations that contributed to their design and this also includes a basic 
understanding of the relation between GA and consciousness. 
2. Consciousness and General Anaesthesia 
Consciousness can be defined as explicit awareness. Awareness implies that the brain is aroused 
and that a person has specific perceptual qualities of an experience (e.g., a hot chocolate drink). The 
term  ―explicit‖  distinguishes  conscious  awareness  from  cognitive  processes  in  the  brain  that  are 
implicit or unconscious. Explicit awareness does not necessarily imply that the patient will also have 
explicit recall, for example the recall of a surgical intervention 21. The key anatomic structures of the 
central nervous system (CNS) that contribute to the state of consciousness are: the brain stem, the 
pons,  the  thalamus  (thalamic  nuclei)  and  the  brain  cortex  with  their  connecting  neural 
pathways 21,22. 
2.1. Molecular and cellular actions of general anaesthetics 
There  are  two  types  of  general  anaesthetics:  (a)  intravenous  agents  (e.g.,  propofol),  generally 
administered together with sedatives or narcotics and (b) volatile agents (e.g., sevoflurane). Both types 
of  anaesthetics  modulate  the  permeability  of  ion  channels  that  regulate  synaptic  transmission  and 
membrane  potentials  in  key  regions  of  the  CNS  14,23,24.  All  general  anaesthetic  agents  are 
relatively apolar, to be able to cross the blood-brain barrier, and interact with their target (i.e., receptor) 
through weak polarization forces and hydrogen bonding 25. The binding of a general anaesthetic to 
its receptor leads to neuron hyperpolarisation due to increased inhibition or to decreased excitation 
thus altering neuronal activity 26. The actions of a general anaesthetic on the molecular level are 
reflected on the brain’s electrical activity as a transition from the low voltage, high-frequency pattern 
of  wakefulness  (known  as  activated  EEG),  to  the  slow-wave  EEG  of  the  deep,  non-rapid  eye 
movement (NREM) sleep, and finally to an EEG burst-suppression pattern 27. 
General  anaesthetics  act  on  different  targets,  i.e.,  receptors,  for  example  -aminobutyric  acid 
(GABA)  type  A,  nicotinic  acetylcholine,  and  glutamate  receptors  (e.g.,  N-methyl-D-aspartate 
receptors) in the brain, as well as glycine receptors in the spinal cord 28,29. A clear distinction has to 
be made between the actions of general anaesthetics and the mechanism of general anaesthesia. The 
actions of general anaesthetics on the brain receptors are well known; the process by which these 
actions  translate  into  general  anaesthesia  (i.e.,  the  mechanism  of  general  anaesthesia)  is  not  well 
understood 21. Sensors 2010, 10                                       
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2.2. Linking the cellular and molecular actions of general anaesthetics with the mechanism of general 
anesthesia. 
Distinct anaesthetic properties are correlated with distinct sites in the CNS; for example, loss of 
consciousness  is  associated  with  the  cerebral  cortex,  loss  of  memory  with  the  limbic  system  and 
immobility and analgesia with spinal cord effects 21. General anaesthetics modulate the activity of 
several CNS structures including the spinal cord, brain stem, pons, thalamic nuclei and specific regions 
of the brain cortex (Figure 2). The effects of general anaesthetics on the brain, which lead to loss of 
consciousness, are best understood at the level of the cortex and the thalamus. 
Figure 2. Key regions (shaded in colour) in the central nervous system that contribute to 
the state of consciousness. 
 
 
The thalamus has numerous connections to the cortex (i.e., the thalamocortical pathway, TCP) and 
individual thalamic nuclei modulate the activities of specific cortical regions. In addition, the cortex 
sends connections back to the thalamus (i.e., the corticofugal pathway, CFP) which greatly outnumber 
the  thalamocortical  connections  14.  The  corticofugal  connections  provide  a  continuous 
depolarization of the thalamocortical neurons, during the brain's wakeful state, preventing them from 
entering a synchronized, oscillatory state. The activity of the TCP is in balance with the activity of the 
CFP through a positive feedback loop 14. A reduced activity of the CFP promotes the activity of the 
TCP, the TCP neurons enter into an oscillatory mode which further reduces the activity of the CFP and 
the subject enters into a sleep-like state (i.e., hypnosis). Most anaesthetics (ketamine is an important 
exception) produce EEG patterns that are reminiscent of spindle and  waves, the EEG landmarks of 
falling  asleep  and  deep,  dreamless  NREM  sleep,  respectively.  Most  anaesthetics  initially  produce  
high-frequency oscillations followed by a lower frequency and a higher amplitude EEG pattern at or 
beyond the point at which consciousness is lost 14. It has been suggested that loss of consciousness 
occurs when information transfer through the thalamus is disrupted during GA following a reduction 
of thalamic metabolism and blood flow 14,30,31. It has also been suggested that the thalamus could 
behave  as  a  consciousness  switch  30.  However,  thalamic  activity  does  not  decrease  with  all 
anaesthetics;  some  general  anaesthetics  (e.g.,  ketamine)  increase  thalamic  metabolism  and  some Sensors 2010, 10                                       
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general  anaesthetics  (e.g.,  sevoflurane)  substantially  reduce  thalamic  activity  without  loss  of 
consciousness  when  applied  in  low  doses  and  lead  to  unconsciousness  at  high  doses  32,33.  All 
anaesthetics will produce sedation at moderate doses. Therefore, it is more likely that the effects of 
general anaesthetics on the thalamus reflect global cortical activity rather than the thalamus acting as a 
consciousness switch 1,22. It has been suggested that efficient communication among cortical areas 
(especialy  among  the  long  range  corticocortical  connections)  requires  a  functional  thalamic 
connection 34,35. A functional thalamic disconnection of the brain cortex, during GA, could still 
lead to cortical arousal, but not to consciousness 22. 
All  cortical  areas  are  not  equally  important  for  the  induction  of  unconsciousness  by  general 
anaesthetics.  A  complex  comprising  the  lateral  temporoparietooccipital  junction  and  the  mesial 
cortical core is most likely the final common target for anaesthetic-induced unconsciousness 22. 
Anaesthetics  disrupt  two  essential  cortical  functions:  cortical  integration  and  cortical  information 
capacity. Anaesthetics may disrupt cortical integration by acting on structures that facilitate long-range 
cortico-cortical  interactions  22.  Anaesthetics  disrupt  synchronization  of  brain  areas  by  delaying 
feedback  interactions  among  distant  (not  adjacent)  brain  areas  within  the  cortex  36  or  between  
small-world  networks  with predominant  local  connectivity and  a few long-range  connections—for 
example the corticothalamic system 37. The corticothalamic system produces global responses 
during  deep  anaesthetic  unconsciousness.  However,  these  responses  are  limited  to  a  stereotypic  
burst-suppression pattern, with a corresponding loss of information, thus creating a system having only 
two possible states (i.e., on or off) 22,38,39. 
General anaesthetics also inhibit the excitatory arousal pathways originating in the brain stem and 
pons or potentiate the sleep pathways that control them 14. The brain stem and pontine nuclei have 
been known to be essential in maintaining cortical arousal and form the so called ascending reticular 
formation 14. 
2.3. Unity of consciousness, cognitive binding and the mechanism of GA 
The concept of unity of consciousness was introduced by the 18th century German philosopher 
Immanuel Kant 21,40. According to Kant, for a perception to have a meaning its distinct qualities 
must be brought together into a single experience. Kant postulated the existence of a mechanism that 
synthesized the diverse and complex processes of the mind to generate a single perception i.e., the 
unity of consciousness 21. The visual system is the best understood model of how the brain processes 
and  integrates  sensory  information.  The  key  question,  also  known  as  the  cognitive  binding  
problem 41 that arose from these studies was: ―How does the brain synthesize the elements of visual 
processing, located at diverse locations of the cortex, to generate a unified visual perception?‖. 
Cognitive binding is necessary, but not sufficient, for the brain to sustain the unity of consciousness. 
The  proposed  mechanisms  for  cognitive  binding  in  the  brain  42,43  are  binding  by  convergence 
(transmission  of  information  from  primary  processing  areas  to  another  region  of  the  brain  for 
integration),  binding  by  assembly  (binding  information  in  a  group  of  inter-related  neurons  whose 
connections grow stronger when repeatedly firing together) and binding by synchrony (coordination of 
neural firing in time associated with neural events at the frequency of about 40 Hz). The evidence from 
GA and sleep studies suggests that loss of consciousness is associated with a breakdown of cortical Sensors 2010, 10                                       
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connectivity, a diminished cognitive binding, a reduction of the repertoire of cortical activity patterns 
(i.e., the predominance of stereotypic responses) and a loss of information 1,21. 
Recently, a ―cognitive unbinding‖ paradigm of GA was proposed to explain the actions of general 
anaesthetics 44-46. To summarize, consciousness is not an all-or-none property, but is graded; it 
increases in proportion to a system’s repertoire of distinguishable states. The shrinking of the field of 
consciousness during GA is proportional to the reduction of the brain’s repertoire of distinguishable 
states. A transition point is reached during GA when a nonlinear collapse of cognitive binding leads to 
loss of consciousness 1,21. A practical application of the concept of cognitive unbinding to GA, the 
―anaesthetic cascade‖ theory, was proposed by John and Prichep 47. The anaesthetic cascade theory 
attempts  to  link  progressive  suppression  of  consciousness  during  GA  with  the  action  of  general 
anaesthetics on specific brain regions. 
2.4. The anaesthetised patient 
The initial signs of GA (stage 1 anaesthesia) can be a state similar to drunkenness, analgesia (the 
inability to feel pain while still conscious), amnesia (loss of memory), distorted time perception or 
increased sleepiness. With higher anaesthetic doses, a patient fails to move in response to a verbal 
command  and  is  considered  to  be  unconscious.  However,  unresponsiveness  during  GA  can  occur 
without unconsciousness. For example, paralyzing agents used to prevent unwanted movements during 
anaesthesia  do  not  remove  consciousness  48.  Most  general  anaesthetics  will  cause  a  global 
deactivation  of  the  brain  at  higher  doses  1.  The  exceptions  are  dissociative  anaesthetics,  like 
ketamine, that increase global brain metabolism, especially in the thalamus 32. The ketamine induced 
changes  in  global  brain  metabolism  are  reflected  in  the  responses  of  the  anaesthetised  patient. 
Ketamine causes loss of motivation to follow commands at lower doses 49; at higher doses ketamine 
causes a characteristic state in which the eyes are open and the face takes on a disconnected blank stare 
consistent with the deactivation of executive circuits in anterior cingulate cortex and basal ganglia 1. 
At doses near the unconsciousness threshold, some anaesthetics block working memory and patients 
may  fail  to  respond  because  they  immediately  forget  what  to  do  50. Also,  some  patients  under 
general anaesthesia can carry on a conversation using hand signals, but  postoperatively deny ever 
being awake during the surgical procedure 51. Surgery is performed when the patient is perceived to 
reach stage 3 general anaesthesia. Increasing doses of modern general anaesthetics (i.e., an overdose) 
do not cause brain death 52 directly but lead to cessation of spontaneous ventilation and impairment 
of cardiovascular function (stage 4 anaesthesia). This stage is lethal without proper cardiovascular and 
respiratory support, which is standard in a modern operating theater.Therefore, monitoring the DGA is 
essential to tailor the optimal dose of general anaesthetic to the individual patient thus reducing the 
incidence of intraoperative awareness or preventing the effects of an overdose of general anaesthetic. 
Although there are several ―brain-function monitors‖ available they have a limited ability to detect 
directly the presence or absence of consciousness, especially around the transition point when loss of 
consciousness occurs 1. This issue will be discussed in detail in Section 4. Sensors 2010, 10                                       
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3. Key Considerations when Designing and Evaluating DGA Monitors 
The  search  for  a  DGA  monitor,  that  would  enable  objective,  reproducible  and  continuous 
measurement of anaesthetic depth, has lead to the development of EEG (electroencephalogram) or 
AEP (acoustic evoked potentials) based monitors 9,17-19. These enable continuous monitoring even 
during conditions during which a patient has lost all responses to external stimuli (to non-painful or 
painful). When interpreting the results of EEG or AEP based monitors it is important to distinguish the 
influences on EEG activity from the influences on EEG measurements. The EEG activity is influenced 
by GA alone, by general anaesthetics 53, by physiological states or by other drugs 54-60 (different 
drugs lead to different changes in EEG activity). 
Most  general  anaesthetics  (e.g.,  propofol,  etomidate,  pentobarbital  or  halothane)  produce 
anaesthesia by increasing the activity of inhibitory  -aminobutyric acid type A receptors (GABAA 
receptors,  a  type  of  ligand  gated  ion  channels) in  the  brain  1,62.  This  is  reflected  in  a  general 
reduction  of  EEG  activity,  accentuated  with  progressive  anaesthetic  concentrations  (Figure  3). 
Exceptions to this rule are ketamine, xenon and nitrous oxide that produce anaesthesia by interacting 
with other brain receptors, mainly, but not exclusively, by inhibiting excitatory N-methyl-D-aspartate 
(NMDA)  brain  receptors  1.  These  three  general  anaesthetics  produce  different  changes  in  EEG 
activity  than  the  so  called  ―GABAA-type  anaesthetics‖  (e.g.,  halothane).  The  division  of  general 
anaesthetics  between  ―GABAA-type  anaesthetics‖  and  ―non  GABAA-type  anaesthetics‖  is  only  a 
convenient  simplification  since  most,  if  not  all  general  anaesthetics,  modulate  (i.e.,  potentiate  or 
inhibit) the activity of several cell membrane channels in the brain. For example, sevoflurane causes a 
major potentiation of the activity of GABA and glycine activated ion channels and a major attenuation 
of the activity of NMDA, 5-HT3 (5-hydroxytryptamine) and AMPA (α-amino-3-hydroxyl-5-methyl-4-
isoxazole-propionate) receptor channels. 
Contrary to expectations, ketamine per se does not change the BIS (bispectral analysis) index value 
even  when  patients  are  unconscious  61.  Administration  of  ketamine,  during  total  intravenous 
anaesthesia with  propofol  and fentanyl,  caused a paradoxical  increase  in  the BIS value  62. The 
explanation for this paradoxical increase in BIS value was that BIS may have detected a concomitant 
and  causally  unrelated  cerebral  hypoperfusion  during  the  combined  ketamine-propofol-fentanyl 
anaesthesia 63-65 since ketamine does not reduce the baseline BIS; also BIS in an empiric score, not 
a pure mathematical construct of raw EEG. Hypoperfusion of the brain can cause changes in EEG 
activity that are visible in the raw EEG record, or more subtle EEG changes that can be detected only 
after  mathematical  analysis.  Supporting  this  explanation  is  the  observation  that  during  ketamine 
anaesthesia the BIS value changed (presumably due to cerebral ischemia) in a patient undergoing 
surgery of the aorta 65. Ketamine has no effects on AEP 67-69, consistent with the observed effects 
of ketamine anaesthesia on BIS values. The effects of nitrous oxide on the raw EEG or on the BIS 
value are varied and therefore unpredictable 61,62,66,70,71. Xenon produces BIS values similar to 
GABAA-type anaesthetics, but some patients with a BIS value suggesting deep anaesthesia, do awake 
from xenon anaesthesia 72. Therefore, current EEG (e.g., BIS) or AEP based anaesthesia monitoring 
devices are not able to reliably assess the patient’s depth of anaesthesia when ketamine, xenon or 
nitrous oxide are used. Sensors 2010, 10                                       
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Figure 3. Relative amplitude changes in EEG frequency bands during pentobarbital (PB) 
and ketamine (K) anaesthesia in an animal model. Legend to colour coded EEG wave 
bands:  black  (),  red  (θ),  blue  (),  green  ()  and  violet  ().  The  solid  horizontal  line 
denotes a deep general anaesthesia; the dotted horizontal line denotes a shallow general 
anaesthesia. 
 
 
-activation and burst suppression are EEG observed changes in the normal brain activity during 
GA. Most general anaesthetics elicit an increase in  EEG frequency band, between 13 and 30 Hz 18. 
Therefore,  EEG-based  depth  of  anaesthesia  monitors  have  to  employ  mathematical  algorithms  to 
compensate for this ― activation‖, to prevent this pattern of EEG activation being reported by DGA 
monitors as arousal 18,73,74. Burst suppression (BS) represents an EEG pattern frequently seen in 
healthy brain at deep levels of anaesthesia 18. This pattern is composed of episodes of electrical 
quiescence (suppression) alternated with high frequency, high amplitude electrical activity (bursts). 
The duration of suppression periods increases with anaesthetic depth. Commercially available DGA 
monitors  have  mathematical  algorithms  that  prevent  the  ―burst‖  intervals  to  be  interpreted  as  
arousal—the patient being awake and reactive to stimuli 75-80. 
Physiological  conditions,  such  as  age  81,82,  race  83,84,  gender  85-87,  low  core  body 
temperature 88, acid-base imbalances 89-91, low blood glucose 92,93 or brain ischemia 62 also 
have a significant effect on the raw EEG. Drugs administered to the patient can influence the EEG 
either through a direct mechanism on the raw EEG  94,95 or by interacting with the absorption, 
distribution  and  elimination  of  the  general  anaesthetic  drug  96.  Of  particular  consideration  are 
neuromuscular blocking agents (used to prevent patient movement and to reduce muscle tone) that 
have a distinct effect on muscle electrical activity and indirectly on the signal quality of the EEG 
measurement 97,98. Useful information can only be extracted from the EEG after pre-processing and 
analysis  in  time  and  frequency  domain  with  numerous  mathematical  techniques  (for  details  
see Section 4). 
The quality of EEG records is mainly influenced by internal or external sources of electromagnetic 
waves. This is the reason for the limited value of raw EEG records to monitor the DGA. Numerous 
sources of interference can distort EEG measurements. Well know sources of interference are the 
electrical  activity  of  head  muscles  99,100  or  heart  pacemaker  101;  other  common  sources  of 
electromagnetic waves are hot air blanket systems 102 and electro coagulation needles 103,104. 
The most important source of interference on EEG is the electrical activity of the muscles (measured Sensors 2010, 10                                       
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with the EMG—the electromyogram). The fast electrical rhythms in the  range (30–100 Hz) in scalp 
(but not intracranial) recordings are predominantly due to EMG activity in conscious humans 105. In 
addition, electrical rhythms in the  frequency range recorded from the scalp are inducible by mental 
activity and are largely due to EMG that is un-related to cognitive effort 105. Since experimental 
evidence links the  EEG frequency band with cognition and by extension to the level of consciousness 
(see Section 2.3 above) it would be possible to confuse changes in the patient’s EMG activity during 
GA with the patient’s state of consciousness during induction or recovery from GA (EMG activity 
alone  has  been  used  as  a  marker  of  anaesthetic  depth,  but  difficulties  in  interpretation  make  this 
approach impractical). 
Auditory evoked potentials (AEP) are the response of the auditory pathway to sound stimuli 17. 
An AEP is calculated by repeatedly applying an auditory stimulus to the patient and averaging EEG 
periods that immediately follow each stimulus, thus eliminating the non-stimulus-related portion of the 
EEG and preserving the specific evoked potentials 17. These potentials can be divided into several 
segments according to the anatomical area of its origin and the time elapsed since the stimulus. The 
middle latency auditory evoked potential, 40 and 60 ms after stimulation, represents neural activity 
within the thalamus and primary auditory cortex and is most often used as a measure of the anaesthetic 
effect 17,106-108. Compared to the raw EEG, AEP are less sensitive to artefacts that are random in 
time  of  occurrence  since  these  artefacts  tend  to  be  eliminated  from  the  EEG  signal  by  repeated 
averaging 17. 
There is no agreement on the minimum level of performance for EEG or AEP DGA monitors 
although many validation studies have been performed (for details see reference 17). A consensus on 
the validation methodology is urgently needed since we still have no direct measure of consciousness 
available in clinical practice and thus no gold standard against which to test EEG or AEP derived 
indices of aesthetic depth 9,19,20. A consensus on the validation method would enable to define a 
minimal level of performance in clinical and experimental settings and facilitate the comparison of the 
vast number of reported trials 19. 
During  GA,  different  patients  loose  consciousness  at  different  (lower  or  higher)  drug 
concentrations.  Also  changes  in  the  patient’s  age  or  general  health  may  require  adjustment  of 
anaesthetic drugs. This variability in anaesthetic drug concentration is caused by a variability in the 
physiological effects of drugs on the body (differences in pharmacodynamics) and by a variability in 
drug metabolism in the body (differences in pharmacokinetics). Therefore it is important to establish 
whether a DGA monitor detects relevant clinical changes (i.e., the transition point between awareness 
and loss of consciousness) independently of the amount of drug needed for that effect to occur, since 
different patients will reach this transition point at different anaesthetic concentrations 9,19,20. 
Improvement of patient outcome should be an essential feature of any DGA monitor. Short term 
benefits (e.g., the amount of anaesthetics used, the recovery time or the length of stay in the recovery 
room) are easy to quantify but of equal importance are the long term benefits like, reduced risks of 
awareness  or  mortality  19.  What  will  ultimately  decide  the  fate  of  any  DGA  monitor  is  its  
cost-benefit ratio to the patient and to society which is validated only by large multicentre trials 19. 
Therefore, a systematic approach to evaluating DGA monitors is necessary to deal with all of the 
above mentioned considerations. Heyse et al. proposed a five step approach to validating the ability of 
anaesthesia monitors to monitor the depth GA 19. These five steps are: (a) validation of the index for Sensors 2010, 10                                       
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detecting  clinical  signs  of  anaesthesia  during  anaesthesia  induction  and  recovery,  
(b)  pharmacokinetic-dynamic  validation,  (c)  validation  of  performance  under  clinical  conditions,  
(d) demonstrating improvement of outcome and (f) demonstrating cost-benefit effectiveness. 
4. Basic Design Characteristics of Current DGA Monitors 
Soft sensors are used to simultaneously process signals, that are observed over time and contain 
random variations and other inaccuracies, to produce values based on signal interactions. Examples of 
software  algorithms  that  can  be  seen  as  soft  sensors  are,  e.g.,  Kalman  filters  109,  neural  
networks  110  or  fuzzy  computing  111.  Implementing  a  soft  sensor  solution  requires  a  sound 
understanding of the process as a whole and specifically of the variable measurements. The procedure 
for implementing a soft sensor solution includes: data and information collection, data analysis and 
modelling,  soft  sensor  model  design,  new  process  knowledge  and  current  expert  knowledge 
amalgamation, implementation and commissioning and performance monitoring. 
From the engineers’ perspective the monitoring of the DGA is essentially a monitoring and control 
system. The key element in this system is a ―soft‖ sensor or virtual sensor consisting of a hardware 
sensor (i.e., EEG or AEP electrodes) that are integrated with custom hardware and software to produce 
a dimensionless number (e.g., on the scale from 0 to 100) indicating the level of general anaesthesia. 
This number is then used by the anaesthesiologist as a reference point to decide whether the level of 
general anaesthesia is appropriate and if not, to increase or decrease the amount of general anaesthetic. 
4.1. Monitoring the DGA 
The process of monitoring depth of GA and administration of a general anaesthetic during surgery 
is  a  closed-loop  control  system  where  the  human  is  responsible  for  reasoning  and  action.  The 
anaesthetists play the roles of controller and actuator by deciding on the amount of anaesthetic and 
when to administer it. On the other hand, the activity of monitoring is performed automatically by 
commercially available DGA monitors. Together they form a closed-loop control system. 
In the last decade several experiments have been performed, where anaesthesia was controlled in a 
closed-loop control system without human interference [114-117]. Although these experiments were 
relatively successful and represent a proof of principle, there is still a long way to the autonomous 
commercially  available  depth  of  GA  control  system.  Additionally,  these  experiments  raise  new 
questions, which have been only partially addressed so far. For example, the challenge is now to 
establish fully the safety, efficacy, reliability and utility of closed-loop anaesthesia for its adoption into 
the clinical environment [119]. Moreover, these systems still have to go trough rigorous testing and 
validation. Additionally, while the closed-loop system can maintain a constant target sedation level it 
cannot adjust the level of anaesthetic delivery in advance to meet the future needs during a surgical 
procedure. On the other hand, this scenario can easily be predicted and successfully resolved by the 
anaesthesiologist  in  communication  with  the  surgeon.  Therefore,  a  closed-loop  control  system  for 
automatic administration of anaesthetic is feasible, but some important practical issues have to be 
addressed. 
The proposed control systems are most often built around a well established BIS monitor, which is 
now  standard  equipment  for  GA  monitoring.  However,  in  the  last  decade  the  BIS  monitor  has Sensors 2010, 10                                       
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undergone rigorous testing, which has shown several drawbacks [118,119]. Therefore the problem of 
constructing an ideal DGA is still unsolved. 
It is a matter of debate how consciousness is formed let alone how it should be measured. In other 
words, we currently rely on indirect measurable quantities, which give us a relatively reliable measure 
of the state of awareness. Several algorithms and methods have been developed for assessment of the 
DGA in the last decade. Their common denominator is the reduction of information, which comes 
from one or more complex signals, into a single feature, which reflects the state of consciousness. This 
concept puts DGA monitoring systems in the domain of software sensors [109,110]. 
4.2. EEG processing 
4.2.1. Time domain analysis 
The time domain analysis deals with the changes of the EEG signal in time. The time domain 
analysis can be based on some morphological features of the signal, e.g., burst suppression. On the 
other  hand  the  analysis  can  be  purely  statistical,  where  mean  and/or  variance  can  be  studied. 
Furthermore,  EEG  is  a  random  non-stationary  signal,  so  the  information  theory  approach  can  be 
applied, where information theory functionals like entropy can be used to determine the degree of 
randomness of the EEG signal. 
Burst suppression 
During deep anaesthesia the EEG may develop a characteristic pattern, which is known as burst 
suppression (BS). It is characterised by alternating periods of normal to high voltage activity changing 
to low voltage. This kind of activity is usually seen when the concentration of anaesthetic drug is  
high  [120,121].  To  quantify  this  effect  the  burst  suppression  ratio  (BSR)  is  calculated.  BSR  is 
calculated as a ratio between the duration of suppression and the duration of bursting.  
Statistical modelling with autoregressive models 
In this case we can approach the problem with techniques that construct models entirely from the 
measurements or time series, which come from the system [122,123]. Since our knowledge about the 
system  is  limited,  we  only  try  to  infer  the  basic  statistical  properties  of  the  system.  This  can  be 
achieved by using linear stochastic models like autoregressive (AR) models. AR models are based 
entirely  on  time  series  data;  therefore  the  terms  they  contain  do  not  have  a  meaningful  physical 
interpretation. However, a successful model can reproduce the statistical properties of original data. 
Information theory and dynamical systems 
Many approaches exist for quantifying different aspects of stochastic signals [124-127]. One such 
approach is by using entropy to quantify the regularity of the system. The entropy can be applied to 
time domain signals as well as to the frequency domain power spectrum. In the latter case it is referred 
as the spectral entropy. Entropy describes the irregularity, complexity of the signal, e.g., a signal which 
is periodically alternating between two fixed amplitudes is completely predictable and has entropy 
value of zero. On the other hand, a signal which is generated by some random process has greater 
complexity and higher entropy. Also, the entropy has the property that it is independent of an absolute Sensors 2010, 10                                       
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scale,  e.g.,  amplitude  and  frequency,  additionally;  the  entropy  can  detect  non-linear  features  of  a 
signal, which makes it an appropriate method for studying EEG signals.  
Symbol Analysis 
Complex systems and their time series can also be studied with a set of methods, which rely on 
symbolic representation of the data. This approach is a crude reduction of information; nevertheless, it 
can be used to enhance the relevant features of the data. It is particularly useful to track qualitative 
changes in the dynamics of the time series [122,123]. When applied to the complex signals like EEG 
the symbol dynamics approach can characterise the non-linear features of the EEG, which can then be 
linked to various depth of sedation. 
4.2.2. Frequency domain analysis 
The  frequency  domain  analysis  is  an  important  approach  to  signal  analysis,  where  the  signal 
features are examined in respect to frequency. With Fourier analysis one obtains amplitude and a phase 
spectrum,  which  is  analogous  to  the  histogram  of  amplitudes  and  phase  angles  of  the  signal 
components [128]. 
Fourier transform 
The  Fourier  Transform  (FT)  plays  a  central  role  in  the  implementation  of  a  variety  of  digital  
signal-processing algorithms, e.g., filtering and spectral analysis [128]. When applied to the analysis of 
the EEG it is mostly used to calculate and derive different spectral features, which are important to the 
depth of GA: absolute and relative power in various frequency bands, spectral entropy, spectral edge 
frequency, median frequency [133,159-161]. 
Bispectral analysis 
In  the  case  of  the  FFT  analysis,  the  phase  spectrum  yields  information  about  the  phase  of 
components  in  relation  to  the  start  of  the  computation  window.  The  bispectrum  measures  the 
correlation  of  phase  between  different  frequency  components  [129,162].  Additionally,  bispectral 
analysis has other features like the suppression of Gaussian noise, thus enhancing the signal to noise 
ratio. Finally, the bispectral analysis is susceptible to non-linear relationships in the signal, which 
makes it very useful for processing the EEG signal. 
4.3. Commercial DGA monitors 
The  first  commercial  EEG-mono-parameter  was  the  Bispectral-Index  or  BIS,  which  was  first 
introduced in 1992 and after 1999 others followed (e.g., Narcotrend, AEP-Monitor/2, PSA, CSM ...). 
These monitoring systems analyse the potential fluctuations measured from the patient’s forehead. 
After the signals are digitalised on the AD converters, the pre-processing unit determines which part of 
the signal is going to be analysed. Next, the artefact algorithm is applied to remove possible artefacts 
stemming  from  eye  movement,  swallowing  or  heart  activity.  The  quality  of  the  artefact  removal 
algorithm is therefore crucial for the reliability of the DGA monitor. On the other hand, these artefacts 
are sometimes used as surrogate parameters, e.g., detection of swallowing determines the steady state 
of GA. Furthermore, the electromyogram (EMG) can also be used as surrogate parameter since the Sensors 2010, 10                                       
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movements  of  the  facial  muscles  are  clearly  visible  in  the  frequency  spectrum  above  30  Hz. 
Consequently,  the  increase  of  the  EMG  surrogate  parameter  is  interpreted  as  a  decrease  of  the 
anaesthetic’s effect and vice versa. Next, algorithms of commercial monitors were trained and tested 
against the signals from the databases. The measured signal is then compared against the samples from 
the database and classified. Consequently, the index is as good as the database against, which it was 
trained. Finally, the calculated index values are post-processed to minimize fluctuations on the output. 
This is done by averaging over past index values, which stabilises the index, but adds delay into the 
index. Therefore, all commercial indices are: (a) constructed abstract quantities that are not directly 
linked to any physiological parameters and (b) have an inherent time delay (Figure 4). In the next 
sections,  we will present  some of the depth  of  anaesthesia monitors, which are in  use in  clinical 
practice and have endured some amount of clinical testing. 
Figure 4. The conceptual diagram of a DGA monitor. 
 
4.3.1. BIS monitor 
The BIS index was first introduced in 1992 by Aspect Medical Systems. The main component of 
the BIS monitor is the bispectral analysis, which evaluates the phase relations from a single channel 
EEG signal measured from the patient’s forehead. The BIS index is a dimensionless number from 0 to 
100. The BIS algorithm is not publicly available; nevertheless, Rampil [131] disclosed some parts of 
the algorithm in 1998. Since the BIS algorithm is constantly updated, the BIS version must be checked, 
when evaluating its performance. 
The basic block diagram of the BIS algorithm is depicted on Figure 5. Firstly, the EEG signal is 
digitised and pre-processed. At this stage various algorithms for artefact detection and removal are 
applied. The most prominent sources of artefacts are: ECG, eye movement/blinking and power grid 
interferences. Additionally, BIS includes two types of BS detection. Firstly, the burst-suppression ratio 
(BSR) detects the portion of the isoelectric EEG in the last 60s, secondly, the QUAZI-Suppression 
detects BS patterns during power grid interferences, which can influence the BSR algorithm. Next, the 
pre-processed data is used to calculate the -ratio parameter. This parameter is calculated as a ratio 
between  empirically  determined  frequency  bands  (30–47  Hz  and  11–20  Hz).  Simultaneously,  the 
second  parameter,  synch-fast-slow,  is  calculated  from  bispectral  analysis.  It  is  defined  as  a  ratio 
between the sum of all spectral peaks between 0.5–47 Hz and the sum of all spectral peaks on the 
interval  Sensors 2010, 10                                       
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40–47 Hz. Finally, all parameters are then fed to the weighting algorithm, which produces the BIS  
index [131-133,162]. 
Figure 5. The block diagram of the BIS algorithm. Abbreviations: BSR (burst suppression 
ratio), electromyogram activity (EMG), FFT (fast Fourier transform). 
 
4.3.2. Narcotrend monitor 
The Narcotrend monitor is produced by MonitorTechnik and was introduced in year 2000. The 
Narcotrend  monitor  classifies  the  state  of  anaesthesia  into  five  stages,  according  to  the  work  of  
Loomis et al. [138]. The stages (A-F) were further subdivided into three sub-stages by the work of 
Kugler [139]. Therefore, the Narcotrend Monitor can automatically distinguish between 14  and 15 
stages (depending on the software version). Additionally, in analogy with BIS, the newer versions of 
the monitor also display the index value (0–100). 
The development of the algorithm was based on a huge database of measurements, which were 
visually classified into five stages. Next, a set of parameters from time domain and frequency domain Sensors 2010, 10                                       
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analyses  were  determined,  e.g.,  several  spectral  parameters,  spectral  entropy  and  autoregressive 
parameters. These parameters were further statistically analysed to detect the parameters, which were 
the  most  suitable  to  discriminate  between  stages.  Finally,  visual  inspection,  classification  and 
extraction of the parameters, were the foundations for the development of the classification function, 
which automatically classifies the EEG into the proposed stages. 
Figure  6.  The  block  diagram  of  the  Narcotrend  algorithm.  Abbreviations:  BS  (burst 
suppression), TD (time domain), FD (frequency domain), electromyogram activity (EMG). 
 
 
Figure 6 shows the algorithm for calculating the Narcotrend index. Firstly, the EEG is recorded 
from three electrodes which are placed on the forehead. Secondly, the digitised signal is subjected to 
extensive artefact detection and removal algorithms. Then, it is analysed in the frequency domain on 
the  frequency  interval  between  0.5  and  47  Hz.  Next,  the  calculated  parameters  are  passed  to  the 
classification function. Meanwhile, the monitor calculates the surrogate parameters, e.g., EMG, which 
are used in plausibility testing of the calculated index [134-136]. 
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4.3.3. AEP-Monitor/2 
Many studies were performed, where the AEP were used to infer the level of GA. However, the first 
commercial monitor based on AEP was introduced by Danmeter in 2001. After further research, the 
same company introduced the new version of the monitor AEP-Monitor/2, which is not only based on 
AEP,  but  includes  also  spectral  EEG  parameters.  The  monitor  uses  autoregressive  models  with 
exogenous input (ARX) to detect the AEP. The ARX were used because the method enables fast 
responses of the monitor. 
Figure  7.  Block diagram  of the algorithm  of the AEP-monitor/2.  Abbreviations:  ARX 
(autoregressive  models  with  exogenous  input),  BS  (burst  suppression),  BSR  
(burst  suppression  ratio),  BPF  (band  pass  filter),  EMG  (electromyogram  activity),  
AAI (AEP-ARXI), SNR (signaltonoise ratio). 
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Like other successful DGA monitors the new version of the index calculates also the AEP-ARX-
Index  (or  AAI—A-line  autoregressive  index),  which  is  a  dimensionless  number.  Unlike  other 
monitors, AAI can be displayed on two scales: either from 0 to 100, or from 0 to 60; the second scale 
is  recommended  and  the  optimal  anaesthesia  is  achieved  if  the  index  values  are  between  15  
and 25. 
The algorithm of the AAI index is shown on Figure 7. First, the monitor records EEG, while the 
short bilateral clicks (2 ms) are emitted through headphones. Second, the monitor digitizes the signal 
and detects and removes artefacts. Next, the signal is put through several band-pass filters (BPF) to 
detect  various  features  in  different  frequency  bands.  The  AEP  are  detected  in  the  frequency  
range 25–65 Hz, with the use of ARX. The reconstructed amplitudes and latencies are evaluated after  
the  ARX  analysis.  Meanwhile,  the  analysis  of  the  EEG  in  frequency  band  between  3–47  Hz  is 
performed by an undisclosed algorithm. Because the EMG is propagated in the same frequency band, 
the AAI can be influenced by the EMG artefacts. Next, the decision how the AAI is constructed from 
AEP and EEG analyses is made by the weighting function, which is based on the signaltonoise ratio. 
Next, the AAI is displayed on the front panel of the instrument. Along with the AAI, additional EEG 
parameters are displayed: the signal quality bar shows the user how the AAI is constructed from its 
components. For additional information, the burst suppression ratio and EMG bars are also displayed 
alongside the AAI. All of the above parameters must be monitored simultaneously in order to ensure 
optimal sedation of the patient during GA [140-143,148]. 
4.3.4. PSA 4000 Monitor 
The Patient State Analyser 4000 (PSA) was developed by the Physiometrix Company and launched 
in 2001 in the USA. Unlike other indices the PSA monitor calculates the value of the index from four 
EEG channels (see Figure 8). The acquired signals are pre-processed and an artefact removal algorithm 
is applied. Next, the frequency domain analysis is applied to calculate several features of specific EEG 
frequency bands: , , , ,  and of total EEG frequency band (0–50 Hz). 
The PSI uses a set of features that best describe the variances, which are related to the EEG. These 
features  were  derived  from  the  analyses  of  databases  obtained  in  previous  studies.  The  databases 
contain a huge number of EEG measurements and were used to: (a) develop  an artefact detection 
algorithm, (b) determine features for description of anaesthesia states and conditions and (c) calibrate 
the  PSI  index.  Next,  the  set  of  features  found  to  account  for  most  statistical  variance  related  to 
hypnotic  state  (selected  from  database  recordings)  were  derived  for  input  to  the  discriminant 
algorithm. These features include measures such as: (a) absolute power gradient between frontpolar 
and vertex regions in , (b) absolute power changes between midline frontal and central regions in  
and between midline frontal and parietal region in , (c) total spectral power in the frontpolar region, 
(d) mean frequency of the total spectrum in midline frontal region, (e) absolute power in the  band at 
the vertex and (f) posterior relative power in slow . 
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Figure 8. The block diagram of the algorithm of the PSA 4,000 monitor. Abbreviations: 
BSR (burst suppression ratio), FFT (fast Fourier transform), PSI (patient state index). 
 
 
All features are included in a plausibility analysis to calculate the Patient State Index (PSI), which is 
a dimensionless number from 100 (awake) to 0 (isoelectricity). Additionally, surrogate analysis is 
performed by calculating two parameters: BS and arousal detection. This means that both parameters 
modulate PSI index in the case when the signal quality is under question. Finally, before the index is 
displayed, it is post-processed with an averaging algorithm, to provide a more stable output [144,145]. 
 Sensors 2010, 10                                       
 
 
10915 
4.3.5. IoC Monitor 
The Index of Consciousness (IoC) monitor was introduced by the Morpheus Medical Company. 
The IoC records the electroencephalogram (EEG) with thee surface electrodes attached to the patient’s 
forehead. The main parameter of the IoC is the symbolic dynamics method, which divides EEG into a 
finite number of partitions and assigns a symbol to each partition. The alternation of these symbols 
determines  the  dynamics  of  the  EEG.  The  symbolic  dynamics  detects  the  complex  non-linear 
properties  of  the  EEG  that  can  be  correlated  to  the  depth  of  anaesthesia  [146].  The  IoC  monitor 
incorporates additional parameters: -ratio and EEG BSR. All these parameters are then combined 
through a set of fuzzy logic rules into a single index. Besides IoC, the monitor displays EMG bar 
signal quality bar and BSR. The algorithm is depicted on Figure 9. [146,147]. 
Figure  9.  The  block  diagram  of  the  IoC's  algorithm.  Abbreviations:  BSR  (burst 
suppression ratio), FD (frequency domain), electromyography activity (EMG). 
 
 
4.3.6. Cerebral State Monitor 
The  Cerebral  State  Monitor  (CSM)  was  introduced  by  the  Danmeter  Company  in  2004.  The 
monitor’s algorithm is build upon the EEG-algorithm of its predecessor AEP-Monitor/2 and uses the 
same electrodes. The CSM is a portable, wireless monitor that uses fuzzy logic to calculate the cerebral 
state  index  (CSI).  The  algorithm  is  depicted  on  Figure  10.  Firstly,  one  channel  EEG  signal  is  Sensors 2010, 10                                       
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pre-processed and then processed by an artefact detection and removal algorithm. The pre-processed 
signal is then used to calculate three parameters in frequency domain: (a) ratio, (b) ratio and (c) 
-ratio. Additionally, the BS analysis is applied to calculate the BSR. Afterwards, all parameters are 
fed to a fuzzy logic inference system to calculate the cerebral state index (CSI). Finally the CSM 
displays the CSI, BSR and EMG values [148]. 
Figure 10. Block diagram of the algorithm of the CS Monitor Abbreviations: BS (burst 
suppression),  BSR  (burst  suppression  ratio),  FD  (frequency  domain),  electromyogram 
activity (EMG), CSI (cerebral state index). 
 
4.3.7. Entropy-Module 
The Entropy Module was introduced in 2003 by the Datex-Ohmeda Company. The product is based 
on many studies [150,151,161], which show that entropy could be used to characterise the EEG and 
the depth of GA. The main idea is that increasing depth of anaesthesia causes increase in regularity of 
the EEG, which can then be inferred by the entropy and used to estimate the depth of anaesthesia. 
A block diagram of the monitor's  algorithm is  presented on Figure 11. The first step of index 
calculation is the digitalisation of a single channel EEG. Then, the monitor applies pre-processing Sensors 2010, 10                                       
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algorithms. Next, the digitised signal is put through the artefact detection and removal algorithm. After 
that, the signal is divided into two frequency bands (0.8–32 Hz and 0.8–47 Hz).  
Figure  11.  Block diagram  of the Entropy module algorithm. Abbreviations: BS (burst 
suppression),  BPF  (band  pass  filter),  BSR  (burst  suppression  ratio),  FFT  (fast  Fourier 
transform). 
 
 
The FFT of the signals is performed with various window lengths. This technique is similar to the 
multi-scale analysis, e.g., wavelet analysis, where different window lengths ensure optimal resolution 
for each frequency band. The spectral  entropy is then calculated from the power spectrum of the 
particular epoch of the signal within a particular frequency band. According to the aforementioned 
frequency bands, two features are calculated: state entropy (SE) and response entropy (RE). Both are 
dimensionless numbers between 91-0 and 100-0, respectively. Additionally, the monitor performs the 
BS analysis and displays the BSR. The main difference from other DGA monitors is that this monitor 
outputs two index values. While the SE includes information only from EEG, the RE also includes the 
EMG  activity  and  can  be  therefore  used  as  a  surrogate  parameter.  Consequently,  the  difference 
between indices, which is larger than 10 indicates increased muscle activity. In conclusion, the monitor Sensors 2010, 10                                       
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does not perform any fusion of the calculated features into a single index like in the previous cases 
(e.g., BIS). Therefore, the interpretation of the results is left entirely to the anaesthetist [79,149,150]. 
5. Comparison of the Technical Properties among DGA Monitors 
In this section we discuss the key qualities that are shared among the DGA monitors, as well as the 
differences that may be important for the performance of a DGA monitor in clinical practice. These 
qualities are summarised in Table 2. 
5.1. The use of a priori knowledge in development of the decision making algorithm 
The iterative process in development of the index algorithm improves its quality and reliability. In 
this process the algorithm should be refined against a high quality database with expert interpretation. 
In  this  regard  several  publications  exist  about  the  development  of  the  BIS,  Narcotrend  and  PSA 
monitor algorithms [131,134,144]. BIS was developed in an iterative process, where the discriminating 
parameters were tested for performance against a database of EEG measurements related to different 
anaesthesia states [131]. The Narcotrend algorithm was developed in a similar fashion, where the 
database was visually inspected and classified into stages. The classified data then served to extract the 
time and frequency domain features to be used in classification function [134,137]. The development 
of the PSI algorithm was based on three databases of EEG records, which were used for development 
of artefact detection and removal algorithms, classification algorithms and finally a third database was 
used for calibrating the index [144]. On the other hand little is known about the inclusion of prior 
knowledge in the development of other indices (AAI, SE, CSI and IoC). This does not mean that the 
monitors were not tested and calibrated against real EEG signals, however, the size of the database and 
the  development  process  are  an  important  property  of  the  DGA  monitor  and  can  reflect  the 
discriminating power of the index. 
5.2. Features for calculating the DGA indices 
After the pre-processing stage of the data analysis all indices calculate features, which are used for 
index calculation. The number and type of features vary from monitor to monitor, although, most of 
the features are established empirically and do not reflect any underlying determinism. Exceptions are 
BIS, Narcotrend and AEP-Monitor/2 (AAI). The BIS performs a bispectral analysis of the EEG signal 
and analyses the phase relationships of the EEG components. Here, a weak assumption of the model 
can  be  made,  that  the  phase  relationships  are  connected  to  the  number  of  different  oscillatory 
generators in the brain [131]. The Narcotrend uses autoregressive (AR) modelling to infer different 
features  [134,148]. Also, the AEP-Monitor/2  uses AR  models  to  infer  AEP  from  the EEG [140]. 
However, AR models are only used for modelling statistical properties of the signal; therefore, it is not 
possible to infer the underlying dynamics of the signal. At the same time, Narcotrend uses a set of 
empirical features based on spectral power: spectral edge frequency and -ratio.  Sensors 2010, 10                                       
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Table 2. Comparison of DGA monitors. 
  BIS  Narcotrend  PSA 4000 
AEP-
Monitor/2 
Entropy 
Module 
CSM  IoC 
Database 
included in the 
development of 
algorithm or for 
inferrence 
Yes  Yes  Yes 
No; index 
based on 
previous 
studies of the 
algorithm 
No; index 
based on 
previous 
studies of the 
algorithm 
No; index 
based on 
previous 
studies of the 
algorithm 
No; index 
based on 
previous 
studies of the 
algorithm 
Features or 
methods 
included in 
algorithm 
Bispectral 
analysis, 
beta-ratio 
SEF, median 
fr., spectral 
entropy, 
relative 
,,,, 
AR model 
Several 
frequency 
domain 
features 
extracted 
from power 
spectrum 
AEP, ARX 
model 
Multiscale 
analysis, 
entropy, 
spectral 
entropy 
, , - 
power ratios 
Symbol 
dynamics 
analysis 
Surrogate 
analysis 
No  Yes  Yes  Yes  No  No  No 
Burst 
suppression 
analysis 
Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Index 
calculation  
Weighted 
sum of 
subparame-
ters 
Classifica-
tion function 
with 
plausibility 
analysis 
Plausibility 
analysis with 
surrogate 
testing 
against BSR 
and arousal 
parameters 
Modulation 
of index 
based on SNR 
and EMG 
Entropy, no 
inference 
algorithm 
Fuzzy logic 
inference 
system 
Fuzzy logic 
inference 
system 
Estimated time 
delay (deep 
anaest. → 
awake, awake 
→ deep anaest.) 
63 s / 61 s  90 s /26 s 
Data not 
available 
Data not 
available 
Data not 
available 
106 s / 55 s 
Data not 
available 
Susceptibility to 
EM interference 
Moderate  Moderate 
Data not 
available 
Data not 
available 
High  Moderate 
No data 
available 
Agreement with 
clinical signs of 
anaesthesia 
Yes  Yes 
More studies 
needed 
Yes  Yes  Yes 
More studies 
needed 
Appropriate for 
ketamine or 
N2O anaesthesia 
No  No  No  No  No  No 
No data 
available 
Papers on adult 
anaesthesia 
cited in Pubmed 
878  53  5  19  109  21  2 
Papers on child 
anaesthesia 
cited in Pubmed 
122  8  2  5  3  4  0 
Outcome 
improvement 
Yes, but more 
studies 
needed 
Yes, but more 
studies 
needed 
Data not 
available 
Data not 
available 
Data not 
available 
Data not 
available 
Data not 
available 
Cost 
effectiveness 
For selected 
high risk 
patients 
Data not 
available 
Data not 
available 
Data not 
available 
Data not 
available 
Data not 
available 
Data not 
available Sensors 2010, 10                                       
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A similar approach was used for the PSA, where a set of spectral features were established from 
database EEG records [144]. The same approach is also used by the CSM, which is based on  and  
power ratios [148]. An alternative approach is used by the Entropy Module (SE and RE) and the IoC 
Monitor. In the first case the spectral entropy calculation is combined with multi-resolution analysis, 
which yields an optimal time-frequency resolution. The entropy can be regarded as an estimator of 
signal complexity and is assumed to be related with the DGA [150,151]. Moreover, it can detect non-
linear features in the signal. A similar principle is used by the IoC monitor, which analyses the symbol 
dynamics of the EEG signal. Finally, while the indices mostly differ in the number and type of features 
used, the BSR is calculated by all monitors and is included either in the index calculation algorithm, or 
is displayed as additional information for the anaesthetist [18,148]. 
5.3. Algorithms for calculating the DGA indexes 
After the feature extraction is completed, each monitor uses a different algorithm to calculate or 
classify the DGA. BIS calculates its value by a simple weighted sum of features [131]. The weighing 
function is most probably modulated by the state of anaesthesia, since a linear dependence on BSR in 
deep anaesthesia has been demonstrated in [132]. Narcotrend monitor uses a classification function, 
which  derives  the  state  of  anaesthesia  from  the  extracted  features.  Additionally,  the  Narcotrend 
monitor calculates additional surrogate parameters, which are sensitive to atypical patterns of general 
anaesthesia, e.g., K complexes [134]. These parameters are then used in a plausibility analysis before 
the index is displayed. This is the probable reason for Narcotrend's better performance in comparison 
with BIS regarding the susceptibility to increased EMG activity [152]. Similarly, the AEP-Monitor/2 
(AAI)  also  has  a  weighting  function  to  calculate  the  index  from  the  ARX  model.  The  weighting 
function is modulated by the signal quality and the presence of artefacts. Although, the modulation 
function implies that the influence of the artefacts on the final index is accounted for, the values of 
AAI and BIS have decreased significantly in a study where muscle relaxants were administered to the 
ICU  patients  [153,155].  The  PSA  first  conducts  a  plausibility  analysis  to  classify  the  state  of 
anaesthesia from the values of spectral features. Additionally, it performs surrogate analysis to test 
against  artefacts  and  BS.  A  specific  approach  has  been  taken  by  the  Entropy  Module,  where  the 
monitor  uses  no  special  inference  algorithm  but  rather  relies  on  two  normalised  spectral  entropy 
values:  state entropy (SE) and response entropy  (RE).  The authors  argue that  artefacts  like  EMG 
should be treated as a signal and are therefore included in the RE number [79]. The anaesthetist should 
look for a difference between the SE and the RE, where a difference larger than 10 indicates the 
presence of significant EMG interference in the EEG signal. The IoC Monitor and CSM both use a 
fuzzy logic set of rules to produce an index. Although the CSM includes the artefact control function, 
the features are calculated on the frequency bands which could include EMG activity. Although, a 
comparative study showed that EMG had no effect on CSM or BIS index in children, an open question 
remains how much influence the EMG has on the CSM in adults [156]. Additionally, a case report 
indicates  a  strong  correlation  between  EMG  and  CSM  in  an  ICU  patient  [154].  Finally,  the  IoC 
Monitor, which also calculates the index via a fuzzy inference system, excludes the EMG variable 
from the algorithm. Alternatively it displays the EMG value separately and it is up to the anaesthetist Sensors 2010, 10                                       
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to decide how to react to the increased EMG values. The authors stress the fact that a sudden change in 
the IoC, accompanied by a rise of EMG, is probably the effect of increased muscle activity [147]. 
5.4. The response time of DGA monitors 
One of the most important parameters of a DGA monitor is its response time (i.e., time delay) to a 
rapid change in the level of sedation. Unfortunately, not many studies have been performed where this 
parameter was tested. Zanner and co-workers used recorded EEG data to test the responsiveness of the 
DGA indices [157]. The data were selected to represent an awake state, a general anaesthesia and a 
suppression of cortical activity. Then the authors measured the response time of BIS and Narcotrend 
monitors to these EEG signals. The study reported time delays between 26 ±  7 seconds and 106 ±  23 
seconds for the transition between EEG suppression and the awake state for BIS, Narcotrend and CSM 
(see Table 2 for details). Additionally, the study showed that the time delays were not constant and 
were dependent upon the depth of GA. Also, the response times were different for the increasing and 
decreasing states of GA. Next, a similar study was performed, where the authors used simulated EEG 
signals  on  the  same  monitors  [158].  The  time  delays  fluctuated  between  14  seconds  and  
155 seconds, also, the rise and fall times did not match for the same DGA index. Therefore, both 
studies raise concerns about the timely detection of rapid EEG changes concomitant with the transition 
from general anaesthesia to awareness. Additionally, these findings limit the use of DGA monitors for 
pharmacodynamic modelling. Similar studies for other DGA indices have not been published to date. 
5.5. Advantages and disadvantages of different DGA monitors 
Despite the abundance of studies on commercial DGA monitors, it is still difficult to compare their 
performance because there is no consensus on the validation methodology [19] and the majority of 
studies have been performed on the minority of DGA monitors (i.e., BIS, Narcotrend and Entropy 
module). Despite the aforementioned problems, the fact that the BIS monitor has been present for 
almost two decades and has been evaluated by many studies, makes it a de facto standard against 
which  all  other  DGA  monitors  are  compared.  The  BIS  and  Entropy  monitor  are  the  only  DGA 
monitors  that  have  been  routinely  used  in  child  anaesthesia  163-168.  However,  this  does  not 
necessarily mean that the  BIS monitor is  superior to  other DGA monitors  in  all other aspects  of 
anaesthesia monitoring. 
Some conclusions can be made about the performance of individual DGA monitors by analyses of 
the inferred characteristics of their DGA algorithms (only conceptual descriptions of DGA algorithms 
were published, no DGA algorithm has been published with full technical specifications so far). The 
influence of various interferences  on DGA index can be studied by  checking for the presence of 
surrogate analysis in the respective algorithm. It can be expected that BIS would have more problems 
with EMG interference than Narcotrend, which was shown in [169]. This is most likely due to the fact 
that Narcotrend modulates the index value with artefact surrogate analysis. Susceptibility to EMG 
interference is expected in monitors that have a DGA algorithm similar to the PSA monitor. The 
performance of artifact removal algorithms was tested in [170], where it was shown that Narcotrend’s 
artifact  removal  algorithm  was  more  likely  to  exclude  the  data  from  further  analysis,  due  to  the 
presence of artifacts. Unfortunately, no such claims could be made for other monitors, due to lack of Sensors 2010, 10                                       
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similar studies. The complexity of the algorithm is an important property, which also influences the 
time delay or the response time of a monitor to an abrupt change in sedation. Here BIS, IoC and 
Entropy  Module  DGA  monitors  are  advantageous,  since  their  algorithms  are  simple,  that  is,  they 
include  few  FD  or  TD  features.  This  fact  was  shown  in  recent  articles  [171,172],  where  BIS 
outperformed the Narcotrend, PSI and CSM monitor. Here, despite the fact that CSM has a simpler 
algorithm in comparison to Narcotrend, it was the slowest to respond to a change in sedation. Burst 
suppression is an important indicator of the level of deep sedation. The BSR is therefore included in 
every DGA monitor. The way it is incorporated into the algorithm might have the influence on the way 
monitors react different or extreme conditions like oversedation. The monitors like BIS, Narcotrend, 
IoC,  CSM  might  have  an  advantage,  since  the  BSR  analysis  is  directly  included  in  the  index 
calculation, while on the other hand, monitors like AEP-Monitor/2, PSA and EntropyModule use BSR 
analysis in surrogate analysis to modulate the value of the index or in some cases display the value of 
BSR independently. This fact was reflected in the study [173], where BIS outperformed the PSI (PSA) 
in the prediction of oversedation. 
Recently, two studies compared the monitoring of GA with the BIS and the CSM (marketed as a 
low cost DGA monitor) during propofol/remifentanil [174] and propofol/fentanil anaesthesia [175]. In 
the first study, the CSM was a satisfactory alternative to the BIS for monitoring hypnotic effect in 87% 
of patients; in 13% of the patients, the CSM displayed values indicating an awake state despite clinical 
sleep, all correctly identified with the the BIS [174]. In the second study, propofol anaesthesia guided 
with the CSM resulted in 20% higher propofol doses compared with the BIS; there were no clinically 
relevant differences in recovery times [175]. 
The DGA monitoring technology is promising and used widely, nevertheless to date no health 
authority  has  so  far  recommended  that  such  monitors  should  be  compulsory  during  general 
anaesthesia, but should be considered only on an individual basis [176]. 
6. Towards a Better DGA Monitor 
There is a growing interest in EEG-based DGA monitors, which is illustrated by the increasing 
number of new DGA monitors that are used in clinical practice. The pace of development of future 
DGA  monitors  will  depend  on  two  types  of  changes:  changes  in  the  validation  process  and  the 
introduction of new concepts in the design of mathematical algorithms that interpret EEG signals 
during  GA.  The  validation  process  of  EEG  or  AEP  derived  indices  of  aesthetic  depth  would  be 
accelerated  if  a  consensus  could  be  reached  on  a  validation  protocol  19.  Most  likely,  such  a 
validation process would have to be developed and coordinated by an international professional body. 
Several algorithms were developed for the calculation of EEG or AEP derived metrics but most have 
not been published fully or not at all. The practice of using open-source algorithms for development of 
future DGA monitors would accelerate the improvement of existing DGA monitors and hasten the 
arrival of the next generation 20. The key challenge that faces the developers of DGA monitors is the 
design  of  algorithms  that  measure  the  transition  from  consciousness  to  shallow  and  then  to  deep 
anaesthesia  independently  of  the  type  and  concentration  of  a  general  aesthetic  needed  for  these 
transitions to occur. Current DGA monitors do not measure the state of consciousness directly, but can 
still  assess  quite  well  the  transition  point  when  loss  of  consciousness  occurs  for  most  general Sensors 2010, 10                                       
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anaesthetics with the exception of ketamine, nitrous oxide or xenon 19,20. For the same reason no 
currently  available  DGA  monitor  distinguishes  among  the  waking  state,  anaesthetic-  induced 
unconsciousness,  REM,  and  non-REM  sleep.  This  deficiency  has  important  practical  
consequences—i.e., it is not always possible to detect a sleeping patient before surgical stimulation 
causes  arousal  and  awareness  19.  A  potentially  promising  way  forward,  in  the  development  of 
algorithms for monitoring the DGA, would be the correlation of information integration in the brain 
with  different  stages  of  unconsciousness  20.  As  discussed  previously,  the  loss  of  consciousness 
during  GA  seems  to  be  associated  with  a  breakdown  of  cortical  connectivity  with  concomitant, 
quantitative and qualitative changes in the flow of information 1,21. 
To  maintain  an  appropriate  depth  of  GA,  anaesthesiologists  routinely  increase  the  delivered 
anaesthetic concentration in  anticipation  of increased surgical  stimulation. Rö pcke and co-workers 
systematically studied the EEG concentration-response relationship of desflurane and concluded that 
surgical stimulation shifted the desflurane concentration—electroencephalographic effect curves for 
the BIS index toward higher desflurane concentrations [177]. DGA monitors discussed in this review 
are essentially monitoring only the hypnotic component of GA and do not evaluate the patient’s stress 
level during surgery (i.e., the nociceptive component of GA). For example, during GA maintained with 
desflurane or propofol, a surgical incision (a painful stimulus) has modest effects on the EEG patterns; 
these effects are not strongly modified by the depth of anaesthesia as estimated by the BIS 178. The 
monitoring of stress response during surgery is important, because prolonged surgical stress can lead to 
increased morbidity and delayed postoperative recovery 179-181. Surgical stress reflects the balance 
between  nociception—the  neural  processes  of  encoding  and  processing  painful  stimuli  and  
anti-nociception—a  reduction  in  pain  sensitivity  produced  within  neurons  for  example  due  to  the 
application of drugs that relieve pain. Traditionally, the changes in heart rate and arterial pressure were 
used as  signs  of  increased nociception during  GA but  their specificity and sensitivity is  not  very 
high 182,183. Changes in skin conductance 184 or the number of skin conductance fluctuations per 
second 185 are reported to be more useful for estimating surgical stress then heart rate or arterial 
pressure. Recently, several multivariable approaches for measuring the nociception—anti-nocipection 
balance were developed: the surgical stress index (SSI), the response index of nociception (RN) and 
the noxious stimulation response index (NSRI). The NSRI is computed from hypnotic and opioid 
effect-site concentrations using a hierarchical interaction model; it is reported to better predict the 
analgesic component of anaesthesia than the BIS or AAI index or predicted propofol or remifentanil 
concentrations 186. The RN algorithm combines information on the patient’s reactions and clinical 
signs of nociception, remifentanil levels and estimation of noxious intensity of surgical incision into a 
clinical score from 0 to 100 187. The SSI is based on a sum of ther normalized pulse beat interval 
and the pulse wave amplitude time series of photopletismography. SSI appeared to be a better measure 
of the nociception—anti-nocipection balance than state and response entropy, heart rate or pulse wave 
amplitude 188. Prospective validation studies have yet to be done for all three indices. 
7. Conclusions 
General  anaesthetics  have  been  used  in  medicine  for  more  than  a  century  without  a  clear 
understanding of the underlying physiological mechanisms that regulate the transition from a wake Sensors 2010, 10                                       
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state to an anaesthetic-induced unconsciousness. Recent advances in the field of neurobiology and the 
introduction  of  EEG  based  DGA  monitors  have  made  important  contributions  towards  our 
understanding of fundamental changes in brain activity brought about by general anaesthetics. Current 
DGA monitors directly measure the concentration-dependent affect of a limited number of general 
anaesthetics on the brain and indirectly the state of consciousness during GA; also they do not evaluate 
the patient’s stress level during surgery (i.e., the nociceptive component of GA). The development of a 
true  DGA  monitor,  which  directly  measures  the  state  of  consciousness  and  also  the  nociceptive 
component of GA, would enable, not only a safer and more cost-effective anaesthetic procedure, but 
would also provide us with a key to a deeper understanding of the essence of human being, the one that 
defines us with respect to other living beings, and would give the centuries old philosophical statement 
Je pense donc je suis—I think, therefore I am a profoundly new meaning. 
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